Related Experiment Video

Updated: Jul 12, 2026

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
07:28

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry

Published on: October 29, 2020

THE EFFECT OF PROPAMIDINE ON BACTERIAL METABOLISM

F Bernheim

    Science (New York, N.Y.)
    |September 3, 1943
    PubMed

    Insights

    Propamidine (M/80,000) inhibits bacterial oxidative metabolism, showing a latent period and greater effectiveness at pH 7.8. This indicates a direct impact on bacterial metabolism, distinct from sulfanilamide drugs.

    Area of Science:

    • Microbiology
    • Biochemistry
    • Pharmacology

    Background:

    • Propamidine is an antimicrobial agent.
    • Understanding its mechanism of action is crucial for its effective application.
    • Previous studies suggest potential effects on bacterial processes.

    Purpose of the Study:

    • To investigate the effect of propamidine on bacterial oxidative metabolism.
    • To determine the optimal conditions for propamidine's inhibitory action.
    • To elucidate the mechanism by which propamidine affects bacteria.

    Main Methods:

    • Bacterial cultures were grown in a nutrient medium.
    • The oxidation of nitrogenous compounds in the medium was measured.
    • Propamidine was added at a concentration of M/80,000.
    • Experiments were conducted at different pH levels (6.7 and 7.8).

    Main Results:

    • Propamidine at M/80,000 inhibited the oxidation of nitrogenous constituents.
    • A noticeable latent period preceded the maximal inhibition.
    • The drug was more effective at pH 7.8 compared to pH 6.7.
    • Similar latent period and pH effects were observed for growth inhibition.

    Conclusions:

    • Propamidine directly impacts the oxidative metabolism of bacteria.
    • This mechanism differs from that of sulfanilamide and its derivatives.
    • The findings suggest propamidine's primary action is metabolic inhibition.

    More Related Videos

    Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth09:10

    Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

    Published on: January 7, 2022

    Related Concept Videos

    Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

    Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

    A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
    The drug's acidity or basicity is essential in determining the metabolic...
    Inhibitors of Bacterial Protein Synthesis01:25

    Inhibitors of Bacterial Protein Synthesis

    Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics: Drug–Drug Interactions01:25

    Pharmacokinetics: Drug–Drug Interactions

    Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
    Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

    Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

    In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
    Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

    Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

    Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.